BlackRock
MDXG icon

BlackRock’s MiMedx Group MDXG Stock Holding History

BlackRock’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47M Buy
11,911,300
+577,529
+5% +$2.91M ﹤0.01% 2539
2025
Q4 		$76.7M Buy
11,333,771
+11,311
+0.1% +$79.3K ﹤0.01% 2263
2025
Q3 		$79M Sell
11,322,460
-203,330
-2% -$1.41M ﹤0.01% 2240
2025
Q2 		$70.4M Buy
11,525,790
+1,346,741
+13% +$8.96M ﹤0.01% 2260
2025
Q1 		$77.4M Buy
10,179,049
+582,644
+6% +$4.87M ﹤0.01% 2144
2024
Q4 		$92.3M Sell
9,596,405
-10,437
-0.1% -$81.3K ﹤0.01% 2128
2024
Q3 		$56.8M Buy
9,606,842
+293,004
+3% +$1.94M ﹤0.01% 2397
2024
Q2 		$64.5M Buy
9,313,838
+144,915
+2% +$1.02M ﹤0.01% 2270
2024
Q1 		$70.6M Sell
9,168,923
-364,595
-4% -$2.93M ﹤0.01% 2256
2023
Q4 		$83.6M Buy
9,533,518
+595,624
+7% +$4.36M ﹤0.01% 2183
2023
Q3 		$65.2M Buy
8,937,894
+819,409
+10% +$6.1M ﹤0.01% 2247
2023
Q2 		$53.7M Buy
8,118,485
+160,933
+2% +$820K ﹤0.01% 2437
2023
Q1 		$27.1M Buy
7,957,552
+176,031
+2% +$682K ﹤0.01% 2816
2022
Q4 		$21.6M Buy
7,781,521
+185,606
+2% +$555K ﹤0.01% 2993
2022
Q3 		$21.8M Sell
7,595,915
-59,255
-0.8% -$211K ﹤0.01% 2985
2022
Q2 		$26.6M Buy
7,655,170
+372,395
+5% +$1.46M ﹤0.01% 2927
2022
Q1 		$34.3M Buy
7,282,775
+6,402
+0.1% +$31.3K ﹤0.01% 2814
2021
Q4 		$44M Sell
7,276,373
-123,714
-2% -$859K ﹤0.01% 2742
2021
Q3 		$44.8M Buy
7,400,087
+181,074
+3% +$2.04M ﹤0.01% 2732
2021
Q2 		$90.3M Buy
7,219,013
+5,445,310
+307% +$59M ﹤0.01% 2318
2021
Q1 		$18.3M Buy
1,773,703
+430,086
+32% +$4.16M ﹤0.01% 3229
2020
Q4 		$12.2M Buy
+1,343,617
New +$9.67M ﹤0.01% 3270
2018
Q4 		– Sell
-13,853,596
Closed -$85.6M – 5018
2018
Q3 		$85.6M Sell
13,853,596
-762,073
-5% -$3.44M ﹤0.01% 2063
2018
Q2 		$93.4M Buy
14,615,669
+1,181,588
+9% +$8.41M ﹤0.01% 1987
2018
Q1 		$93.6M Sell
13,434,081
-173,244
-1% -$2.02M ﹤0.01% 1892
2017
Q4 		$172M Buy
13,607,325
+147,214
+1% +$1.8M 0.01% 1496
2017
Q3 		$160M Buy
13,460,111
+1,272,375
+10% +$18.9M 0.01% 1532
2017
Q2 		$182M Buy
12,187,736
+82,382
+0.7% +$1.1M 0.01% 1379
2017
Q1 		$115M Buy
12,105,354
+12,096,517
+136,885% +$102M 0.01% 1684
2016
Q4 		$78K Sell
8,837
-1,401
-14% -$12.6K ﹤0.01% 2700
2016
Q3 		$88K Sell
10,238
-2,627
-20% -$20.8K ﹤0.01% 2675
2016
Q2 		$103K Buy
12,865
+5,351
+71% +$41.6K ﹤0.01% 2519
2016
Q1 		$66K Buy
7,514
+2,618
+53% +$21.8K ﹤0.01% 2219
2015
Q4 		$46K Buy
4,896
+1,758
+56% +$15.2K ﹤0.01% 2103
2015
Q3 		$30K Sell
3,138
-1,578
-33% -$16.7K ﹤0.01% 2153
2015
Q2 		$55K Buy
4,716
+1,940
+70% +$20K ﹤0.01% 1942
2015
Q1 		$29K Sell
2,776
-732
-21% -$6.85K ﹤0.01% 2183
2014
Q4 		$41K Buy
3,508
+1,277
+57% +$12.6K ﹤0.01% 2036
2014
Q3 		$16K Hold
2,231
– – ﹤0.01% 2451
2014
Q2 		$16K Sell
2,231
-41
-2% -$240 ﹤0.01% 2502
2014
Q1 		$14K Hold
2,272
– – ﹤0.01% 2535
2013
Q4 		$20K Buy
2,272
+194
+9% +$1.19K ﹤0.01% 2362
2013
Q3 		$9K Hold
2,078
– – ﹤0.01% 2712
2013
Q2 		$15K Buy
+2,078
New +$14.5K ﹤0.01% 2443

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock's MDXG Position: Q1 2026 in Review

BlackRock increased its MiMedx Group (MDXG) stake by 5.1% in Q1 2026, buying an estimated $2.91M and bringing the position to 11,911,300 shares worth $47M. The position accounts for ﹤0.01% of the portfolio, ranked #2539.

BlackRock first reported a position in MDXG in Q2 2013 and has held it in 44 quarters since. The position peaked at $182M in Q2 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • BlackRock held 11,911,300 shares of MiMedx Group worth $47M as of Q1 2026.
  • BlackRock bought 577,529 MiMedx Group shares in Q1 2026, an estimated $2.91M.
  • MiMedx Group made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2539 holding.
  • BlackRock first reported a position in MiMedx Group in Q2 2013 and has held it in 44 quarters since.
  • BlackRock's MiMedx Group position peaked at $182M in Q2 2017.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.